prolaio eVO2peak Module vs Cardiomo
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if you are a clinician or researcher focused on cardiovascular assessment and require an FDA-cleared software solution to estimate peak oxygen consumption (eVO2peak) using real-world patient data. This tool is ideal for adjunctive aid in clinical evaluation and for high-density, longitudinal data collection in cardiovascular research, leveraging inputs from qualified third-party FDA-cleared wearable medical sensors.
View prolaio eVO2peak Module →Choose Cardiomo if…
Choose Cardiomo if you need a medical-grade wearable device and an AI-powered platform for continuous, remote heart health monitoring, particularly for detecting cardiovascular diseases and providing timely alerts to users and caregivers. This tool is well-suited for ongoing patient monitoring in cardiology, geriatrics, and internal medicine, offering features like continuous vital sign tracking (ECG, heart rate, respiration, skin temperature) and real-time notifications for potential cardiac events or falls.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | Cardiomo |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (software-only, processes remote sensor data) | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo offers a medical-grade wearable device and a mobile app for continuous monitoring, which suggests a more direct and potentially easier user experience for patients. Prolaio's eVO2peak Module is software-only and processes data from third-party sensors, implying a more complex setup and reliance on external devices for data input. Cardiomo's focus on real-time alerts and a user-friendly app for patients and caregivers also points to higher usability for its target audience.
Clinical Value
TieBoth tools demonstrate strong clinical value within their respective focuses. Prolaio's eVO2peak Module is FDA-cleared and clinically validated for estimating peak oxygen consumption, an important metric in cardiovascular assessment. Cardiomo offers continuous vital sign monitoring and AI-powered disease detection with high accuracy for various cardiovascular events, also undergoing FDA approval. Both are adjunctive aids and not standalone diagnostic tools.
Pricing & Value
TieBoth companies list 'contact for pricing,' making a direct comparison difficult. Cardiomo previously offered a public price point of $200 with a $10 monthly subscription, which provides some transparency, though current pricing is not available. Without current public pricing for either, it's impossible to definitively determine which offers better value.
Enterprise Readiness
prolaio eVO2peak ModuleProlaio emphasizes its platform for clinical intelligence, integrating medical insights and data analytics to improve clinical development and research. Its FDA clearance and focus on processing data from qualified third-party sensors suggest a more robust and adaptable solution for various enterprise-level healthcare and research settings. Cardiomo, while offering HIPAA compliance and a cloud platform, appears more geared towards direct-to-consumer or smaller-scale remote patient monitoring deployments.
Innovation
TieBoth tools showcase innovation in their respective areas. Prolaio utilizes a locked deep-learning model to estimate eVO2peak from real-world wearable data, bridging a gap in cardiovascular assessment. Cardiomo integrates a medical-grade wearable with an AI engine for continuous, real-time detection of various cardiovascular diseases and alerts, offering a proactive approach to heart health.
Support & Docs
TieNeither the provided structured facts nor web searches offered specific details on the breadth or depth of support and documentation for either Prolaio or Cardiomo. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | Cardiomo |
|---|---|---|
| Name | prolaio eVO2peak Module | Cardiomo |
| Company | Prolaio | Cardiomo, Inc. |
| Description | Prolaio is a clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Key Features | Estimates peak oxygen consumption (eVO2peak); Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs; Processes data from qualified third-party FDA-cleared wearable medical sensors; Applies a locked deep-learning model for eVO2peak estimation; Provides information as an adjunctive aid in clinical evaluation; Enables high-density, longitudinal data collection; Leverages real-world patient data and insights; Features FDA-cleared software and proprietary algorithms | Medical-grade wearable patch; Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature); AI-powered disease detection (arrhythmias, cardiovascular events); Real-time alerts and notifications; Mobile application (Android and iOS); HIPAA-compliant cloud analytics; Fall detection; Long battery life (up to 7-10 days) |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and Cardiomo.